Haemoglobin Arya: alpha 2-47 (CD5), aspartic acid yields asparagine

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Hemoglobin variants are common genetic alterations affecting oxygen transport.
• Identifying new variants is crucial for understanding hemoglobinopathies and population genetics.

Purpose of the Study:

• To characterize a newly discovered hemoglobin variant, designated hemoglobin Arya.
• To investigate the molecular basis and preliminary stability of this variant.

Main Methods:

• Amino acid sequencing of the alpha chain to identify the substitution.
• Stability testing of the variant hemoglobin at different temperatures (50°C and 55°C).

Main Results:

• A new hemoglobin variant, hemoglobin Arya, was identified, characterized by an aspartic acid to asparagine substitution at residue 47 (CD5) of the alpha chain.
• Hemoglobin Arya was found to be asymptomatic in the carrier.
• The variant exhibited normal stability at 50°C but slight instability at 55°C.

Conclusions:

• Hemoglobin Arya represents a novel alpha chain variant with a specific amino acid substitution.
• The clinical significance of hemoglobin Arya appears minimal, as it is asymptomatic.
• The observed thermal instability suggests potential implications for hemoglobin function under certain physiological conditions.